- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
PharmaResources Shanghai Co Ltd (301230)
PharmaResources Shanghai Co Ltd stock price live, this page displays SZ 301230 stock exchange data. View the 301230 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the PharmaResources Shanghai Co Ltd real time stock price chart below.
What Is the PharmaResources Shanghai Co Ltd Stock Price Today?
The PharmaResources Shanghai Co Ltd stock price today is 35.10.
What Is the Stock Symbol for PharmaResources Shanghai Co Ltd?
The stock symbol for PharmaResources Shanghai Co Ltd is "301230."
What Stock Exchange Does PharmaResources Shanghai Co Ltd Trade On?
PharmaResources Shanghai Co Ltd is listed and trades on the Shenzhen stock exchange.
Is PharmaResources Shanghai Co Ltd a Good Stock to Buy?
Determining whether PharmaResources Shanghai Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 301230 quote. (ISIN: CNE1000065Q9)
What Is the PharmaResources Shanghai Co Ltd Stock Price Today?
The PharmaResources Shanghai Co Ltd stock price today is 35.10.
What Is the Stock Symbol for PharmaResources Shanghai Co Ltd?
The stock symbol for PharmaResources Shanghai Co Ltd is "301230."
What Stock Exchange Does PharmaResources Shanghai Co Ltd Trade On?
PharmaResources Shanghai Co Ltd is listed and trades on the Shenzhen stock exchange.
Is PharmaResources Shanghai Co Ltd a Good Stock to Buy?
Determining whether PharmaResources Shanghai Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 301230 quote. (ISIN: CNE1000065Q9)
Shenzhen
Currency in CNY
35.10
+2.68(+8.27%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.01
36.90
52 wk Range
22.23
52.28
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.0136.90
52 wk Range
22.2352.28
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.22%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.22%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
301230 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.00
Earnings
Latest Release
Apr 29, 2026
EPS / Forecast
0.17 / --
Revenue / Forecast
172M / --
Compare 301230 to Peers and Sector
Metrics to compare | 301230 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship301230PeersSector | |
|---|---|---|---|---|
P/E Ratio | 125.7x | 50.1x | −0.4x | |
PEG Ratio | 1.78 | 0.42 | 0.00 | |
Price/Book | 5.6x | 4.0x | 2.6x | |
Price / LTM Sales | 8.4x | 6.4x | 3.1x | |
Upside (Analyst Target) | - | 2.9% | 48.5% | |
Fair Value Upside | Unlock | −3.1% | 5.8% | Unlock |
PharmaResources (Shanghai) Co., Ltd., together with its subsidiaries, operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally. The company offers contract research organization (CRO), contract manufacturing organization (CMO), contract development and manufacturing organization (CDMO), and commercial manufacturing services for small molecule drugs. It is also involved in the research, development, and customized/commercial production of active pharmaceutical ingredients and key intermediates, including ticagrelor, oxiracetam, l-carnitine, velpatasvir, peramivir trihydrate, huperzine A, and vitamin K2, as well as design, screening, and optimization of hit compounds and lead compounds; conducting of structural improvements; and provision of preliminary safety screening to obtain candidate compounds with outstanding drug properties and intellectual property rights. In addition, the company provides medicinal chemistry, process research and development, pharmaceutical research, molecular building blocks, and pharmacokinetics services. Further, it engages in pharmaceutical technology research and development activities. PharmaResources (Shanghai) Co., Ltd. was founded in 2007 and is based in Shanghai, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the PharmaResources Shanghai (301230) Stock Price Today?
The PharmaResources Shanghai stock price today is 35.10 CNY.
What Stock Exchange Does PharmaResources Shanghai Trade On?
PharmaResources Shanghai is listed and trades on the Shenzhen Stock Exchange.
What Is the Stock Symbol for PharmaResources Shanghai?
The stock symbol for PharmaResources Shanghai is "301230."
Does PharmaResources Shanghai Pay Dividends? What’s The Current Dividend Yield?
The PharmaResources Shanghai dividend yield is 1.22%.
What Is the PharmaResources Shanghai Market Cap?
As of today, PharmaResources Shanghai market cap is 5.80B CNY.
What Is PharmaResources Shanghai's Earnings Per Share (TTM)?
The PharmaResources Shanghai EPS (TTM) is 0.25.
When Is the Next PharmaResources Shanghai Earnings Date?
PharmaResources Shanghai will release its next earnings report on Aug 28, 2026.
From a Technical Analysis Perspective, Is 301230 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has PharmaResources Shanghai Stock Split?
PharmaResources Shanghai has split 3 times.
How Many Employees Does PharmaResources Shanghai Have?
PharmaResources Shanghai has 1155 employees.
What is the current trading status of PharmaResources Shanghai (301230)?
As of Aug 10, 2026, PharmaResources Shanghai (301230) is trading at a price of 35.10 CNY, with a previous close of 32.42 CNY. The stock has fluctuated within a day range of 34.01 CNY to 36.90 CNY, while its 52-week range spans from 22.23 CNY to 52.28 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.